Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CNSP

Cns Pharmaceuticals Inc

Apr 30 • 11:24AM ET

2.30

+0.04 1.77 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: IMMP SLS VTVT CAPR AVTX BTAI OTLK PCRX BLRX KPTI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-41.26	Insider Own	0.00%	Shs Outstand	0.63M	Perf Week	-6.88%
Market Cap	1.86M	Forward P/E	-	EPS next Y	-2.89	Insider Trans	-	Shs Float	-	Perf Month	-3.77%
Enterprise Value	-5.01M	PEG	-	EPS next Q	-5.37	Inst Own	15.31%	Short Float	-	Perf Quarter	-60.28%
Income	-15.85M	P/S	-	EPS this Y	86.62%	Inst Trans	6.73%	Short Ratio	1.83	Perf Half Y	-71.46%
Sales	0.00M	P/B	0.32	EPS next Y	21.25%	ROA	-182.99%	Short Interest	0.06M	Perf YTD	-56.19%
Book/sh	7.15	P/C	0.26	EPS next 5Y	50.48%	ROE	-296.30%	52W High	34.80 -93.39%	Perf Year	-82.33%
Cash/sh	8.89	P/FCF	-	EPS past 3/5Y	95.26% 85.25%	ROIC	-350.48%	52W Low	1.90 21.05%	Perf 3Y	-99.99%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.19% 11.49%	Perf 5Y	-100.00%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	99.75%	Oper. Margin	-	ATR (14)	0.26	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.96	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	41.87	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.96	EPS Q/Q	62.35%	SMA20	-3.98%	Beta	0.54	Target Price	10.00
Payout	-	Debt/Eq	0.07	Sales Q/Q	-	SMA50	-11.97%	Rel Volume	0.20	Prev Close	2.26
Employees	8	LT Debt/Eq	0.00	Earnings	Feb 25	SMA200	-61.35%	Avg Volume	31.86K	Price	2.30
IPO	Nov 08, 2019	Option/Short	No / Yes	EPS/Sales Surpr.	0.00% -	Trades		Volume	2,056	Change	1.77%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)